about
Aggressive chemotherapy and the selection of drug resistant pathogensDuration of antibiotic therapy for bacteremia: a systematic review and meta-analysis.Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.Pharmacoeconomic Analysis of Drugs Used in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India-A Cost-of-Illness Study.Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
How long should we treat community-acquired pneumonia?
@ast
How long should we treat community-acquired pneumonia?
@en
How long should we treat community-acquired pneumonia?
@nl
type
label
How long should we treat community-acquired pneumonia?
@ast
How long should we treat community-acquired pneumonia?
@en
How long should we treat community-acquired pneumonia?
@nl
prefLabel
How long should we treat community-acquired pneumonia?
@ast
How long should we treat community-acquired pneumonia?
@en
How long should we treat community-acquired pneumonia?
@nl
P1476
How long should we treat community-acquired pneumonia?
@en
P2093
Nikole M Scalera
Thomas M File
P304
P356
10.1097/QCO.0B013E3280555072
P407
P577
2007-04-01T00:00:00Z